BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20800105)

  • 1. Identification and development of a promising novel mumps vaccine candidate strain.
    Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
    Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and biological properties of a new live attenuated mumps vaccine.
    Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
    Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.
    Zengel J; Phan SI; Pickar A; Xu P; He B
    Vaccine; 2017 Jul; 35(32):3988-3994. PubMed ID: 28623030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
    Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
    Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
    Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
    Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015.
    Cui A; Zhu Z; Hu Y; Deng X; Sun Z; Zhang Y; Mao N; Xu S; Fang X; Gao H; Si Y; Lei Y; Zheng H; He J; Wu H; Xu W
    PLoS One; 2017; 12(1):e0169561. PubMed ID: 28085897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular epidemiology of mumps virus.
    Mühlemann K
    Infect Genet Evol; 2004 Sep; 4(3):215-9. PubMed ID: 15450201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
    Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
    J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of mumps virus genotype H in two previously vaccinated patients from Mexico City.
    Del Valle A; García AA; Barrón BL
    Arch Virol; 2016 Jun; 161(6):1639-44. PubMed ID: 26935913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
    Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
    Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.
    Sauder CJ; Zhang CX; Link MA; Duprex WP; Carbone KM; Rubin SA
    Vaccine; 2009 Sep; 27(42):5822-9. PubMed ID: 19660591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild and attenuated vaccine RS-12 strains of mumps virus exhibit differences in amino acid sequences of their proteins.
    Alirezaie B; Shahbazi R; Safavieh SS; Mohammad A
    Acta Virol; 2014; 58(3):287-91. PubMed ID: 25283866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monkey neurovirulence test for live mumps vaccine.
    Maximova O; Dragunsky E; Taffs R; Snoy P; Cogan J; Marsden S; Levenbook I
    Biologicals; 1996 Sep; 24(3):223-4. PubMed ID: 8978921
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children.
    Liang Y; Che Y; Yang B; Zhan F; Li H; Guan X; Zhang Y; Yin Q; Li C; Li J; Zhao Z; Liu L; Jiang G; Liao Y; Xu X; Ye J; Ren Q; He Y; Feng M; Wang L; Fan S; Cui X; Wang Z; Li C; Xiao H; Liu R; Li Q; Jiang C; Liu J; Li Q
    J Infect Dis; 2019 Jan; 219(1):50-58. PubMed ID: 30085178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient, reproducible and accurate RT-qPCR based method to determine mumps specific neutralizing antibody.
    Sikazwe CT; Levy A; Speers D; Smith DW
    J Virol Methods; 2020 Mar; 277():113817. PubMed ID: 31911119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete genome sequence of mumps viruses isolated from patients with parotitis, pancreatitis and encephalitis in India.
    Vaidya SR; Chowdhury DT; Jadhav SM; Hamde VS
    Infect Genet Evol; 2016 Apr; 39():272-278. PubMed ID: 26876221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
    Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
    Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
    Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y
    Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic characterization of L-Zagreb mumps vaccine strain.
    Ivancic J; Gulija TK; Forcic D; Baricevic M; Jug R; Mesko-Prejac M; Mazuran R
    Virus Res; 2005 Apr; 109(1):95-105. PubMed ID: 15826917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.